Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calorie Restriction as a Novel Therapeutic Tool to Manipulate Immunity and Improve Therapeutic Potential of First Line Drug Treatments During Relapsing Remitting Multiple Sclerosis

NCT04042415 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT04042415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04042415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calorie Restriction as a Novel Therapeutic Tool to Manipulate Immunity and Improve Therapeutic Potential of First Line Drug Treatments During Relapsing Remitting Multiple Sclerosis
Lead sponsor
Federico II University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 14, 2020
Completion date
September 30, 2025
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caloric restriction, multiple sclerosis, relapsing-remitting